Even before the pandemic, traditional in-person clinical trials were increasing in cost and duration while struggling to recruit and retain participants. As a result, patients in rural and under-served communities were often unable to participate, which created under-represented study groups. Thanks to investments in cloud technology, IoT and AI/ML, organizations can now implement digital engagement platforms, in combination with traditional in-person visits, to decentralize studies through augmented data capture via these digital tools. This approach can improve participant experiences and increase accessibility to a broader and more diverse population.
In this webinar, learn how the Duke Heart Center launched a fully digital, decentralized clinical study leveraging Deloitte’s ConvergeHEALTH MyPath for Clinical platform powered by Amazon Web Services (AWS) to study the impact of COVID-19 on athletes’ heart health. Discover how this important study could give us insights into the impact of COVID on elite athletes, as well as the role that cloud based digital platforms can play to accelerate recruitment and improve retention and event ascertainment to augment the in-person visits that would have been required in the past.
Attend this webinar to learn:
- How the Hearts of Athletes study is being conducted leveraging digital direct to participant platforms to determine the heart’s involvement with COVID-19 in athletes
- The study design and communication strategies that Duke Heart Center utilized to gain approval for a fully virtual study, and how data from their initiative will be used to better understand the heart health of athletes
- How cloud based digital platforms can not only support our understanding of COVID in athletes but also other diseases
- Best practices for development and design of decentralized clinical studies and how to leverage a combination of traditional in-person visits along with augmented data capture through digital tools
- How ConvergeHEALTH platforms powered by AWS Cloud technology can support these trials